Far East Bio-Tec , Ltd. OverviewFar East Bio-Tec , Ltd.'s EBIT is $140M, below the sector sector average of $2.6T.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
As of the most recent data (June 2026), 6886.TWO shows a EBIT of $140M. That is below the sector sector average of $2.6T. Scroll down for historical charts and peer comparison views.
The its sector sector average EBIT is about $2.6T. Far East Bio-Tec , Ltd. is at $140M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how 6886.TWO stacks up against individual peers as well.
Tracking 6886.TWO's ebit over time shows whether Far East Bio-Tec , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $140M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Far East Bio-Tec , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $140M) with ownership activity and broader fundamentals.
